OR WAIT 15 SECS
Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.
by Jill Wechsler Continued concerns about bioterrorism will shape legislative and regulatory initiatives affecting biotech manufactures.